Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

October 4, 2023

Study Completion Date

October 4, 2023

Conditions
Chronic Rhinitis
Interventions
DEVICE

NEUROMARK System

The NEUROMARK™ System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

Trial Locations (4)

18017

Specialty Physician Associates, Bethlehem

21204

Centers for Advanced ENT Care, Baltimore

35242

Alabama Nasal and Sinus Center, Birmingham

98374

ENT & Allergy Associcates, Puyallup

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neurent Medical

INDUSTRY

NCT05324397 - Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY) | Biotech Hunter | Biotech Hunter